s.okonkwo

TL2 · Kristiansand

Contributes reviews on supplier material. Based in Kristiansand.

Joined 8 July 2025 · last posted 8h

83 posts, newest first. Showing up to 150.

Documenting a supplier's response to a discrepancy Replied, post #50 · Sourcing › Vendor reports · 28 Jul 2026 · 15 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. The uncertainty is in the assumption, not…
Here for the analytics and not much else Replied, post #100 · Lounge › Introductions · 27 Jul 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #48 · Practice › Dosing & titration · 26 Jul 2026 · 26 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
I joined for one answer and stayed for a year — what changed my mind Replied, post #104 · Start Here › Welcome · 23 Jul 2026 · 4 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #64 · Practice › Interactions · 19 Jul 2026 · 0 likes Antibiotics: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #49 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 0 likes On post #45 — agreed on the reasoning, with one qualification. Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280…
Journal club: LEADER as the historical anchor Replied, post #106 · Evidence › Journal club · 18 Jul 2026 · 2 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Research-use-only status: what it means legally and practically Replied, post #77 · Compounds › Other compounds · 18 Jul 2026 · 0 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #55 · Clinical › Bloodwork · 11 Jul 2026 · 26 likes Same experience here, different supplier, so it is at least not unique to one of them.
How shortages have affected compounding permissions Replied, post #28 · Access › Shortages · 10 Jul 2026 · 32 likes Where an alternative within the class is available, the comparison is a clinical one and the doses are not equivalent. Caveat: everything above assumes the paperwork is…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #28 · Compounds › Retatrutide · 9 Jul 2026 · 0 likes Post #27 is the version of this I will quote in future. One addition. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What…
Preservatives: function, testing, and limits — one year on Replied, post #29 · Pharmacology › Formulation chemistry · 5 Jul 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Journal club: what we got wrong in an earlier session Replied, post #44 · Evidence › Journal club · 1 Jul 2026 · 12 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Tracking a shortage from primary sources rather than rumour Replied, post #67 · Access › Shortages · 24 Jun 2026 · 0 likes Worth separating tracking a shortage as a question about the compound from tracking a shortage as a question about the documentation. They get answered by different…
Electrolyte supplements: which ones do anything Replied, post #35 · Nutrition & Training › Hydration & electrolytes · 20 Jun 2026 · 32 likes I read post #33 twice before replying, because I had assumed the opposite. Cramping is the symptom most confidently attributed to electrolytes and has the weakest…
About the Receptor biology category Replied, post #3 · Pharmacology › Receptor biology · 15 Jun 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Injection volume, overload, and peak distortion Replied, post #30 · Analytics › HPLC & UHPLC · 1 Jun 2026 · 22 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Why this subcategory is stricter about sourcing than most Replied, post #32 · Compounds › Secretagogues & GH axis · 20 May 2026 · 21 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #9 · Clinical › Comorbidities · 15 May 2026 · 0 likes On post #5 — agreed on the reasoning, with one qualification. The question underneath Type 2 diabetes is usually "how would I tell?" rather than "what is true?", and…
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #8 · Start Here › How to Ask · 13 May 2026 · 13 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Reference intervals: how they are constructed and why one in twenty flags Replied, post #96 · Clinical › Bloodwork · 13 May 2026 · 0 likes Everything in post #94 holds. The case it does not cover is the one I have. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from…
Revisiting: Absolute versus relative contraindications Replied, post #85 · Safety › Contraindications · 8 May 2026 · 15 likes Noted, and thank you for writing it out rather than summarising it.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #13 · Evidence › Journal club · 3 May 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Coming back to: A structured critique template this community uses Started this topic · Evidence › Study critique · 22 Apr 2026 · 45 likes Posting this under the heading it deserves: A structured critique template this community uses Everything below is what sits behind that. Reading back through what has…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #53 · Practice › Reconstitution · 21 Apr 2026 · 7 likes Picking up post #50: that is the part I would want checked first. The best check on any reconstitution calculation is to do it twice by two different routes — mass per…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #43 · Sourcing › Logistics · 15 Apr 2026 · 0 likes Answering the question post #39 raises rather than the one it answers. Peak periods and public holidays affect this more than any other factor and are entirely…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #75 · Clinical › Bloodwork · 4 Apr 2026 · 33 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Publication bias detection and its low power — does this still hold? Replied, post #19 · Evidence › Meta-analyses · 23 Mar 2026 · 18 likes Useful. I have added it to my own notes with the date on it.
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #107 · Clinical › Bloodwork · 21 Mar 2026 · 0 likes Coming back to post #104, because the follow-up matters more than the original answer. Add biological variation and analytical imprecision to that base rate and the…
Grapefruit: why this class is not the class that cares Replied, post #34 · Practice › Interactions · 12 Mar 2026 · 4 likes I read post #30 twice before replying, because I had assumed the opposite. I would be cautious about generalising from the grapefruit example above. It is a good…
Search filters: what is missing Replied, post #34 · Meta › Site feedback · 9 Mar 2026 · 0 likes Post #32 put the caveat in the right place and I want to underline it. On search filters the community has more anecdote than the confidence in this thread implies, and…
Choosing which test to pay for, given a fixed budget Replied, post #15 · Sourcing › Independent verification · 6 Mar 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Old habit: I write down the expected…
Insomnia at a dose step: reported experiences — the long version Started this topic · Wellbeing › Sleep · 3 Mar 2026 · 19 likes Insomnia at a dose step: reported experiences — the long version Writing it up because I had to work it out twice and would rather nobody else did. A sleep question…
Trifluoroacetate content and its consequences Replied, post #39 · Analytics › Impurities & related substances · 28 Jan 2026 · 0 likes Adding the measurement that post #37 says would settle it. The most useful reply I ever got about trifluoroacetate content was a request to state my units. It sounds…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #96 · Practice › Interactions · 24 Jan 2026 · 11 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #94 · Compounds › Semaglutide · 15 Jan 2026 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Second pass at: Metformin co-administration and additive GI effects Replied, post #26 · Practice › Interactions · 31 Dec 2025 · 10 likes Before the thread moves on from Metformin co-administration — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #43 · Sourcing › Regulatory · 23 Dec 2025 · 2 likes The most useful thing anyone has posted about compound being unapproved in this category was a table of what had been measured and by whom. That is what I would want…
Publishing an inconvenient result: a case study — the long version Replied, post #74 · Sourcing › Independent verification · 17 Dec 2025 · 8 likes Answering the question post #70 raises rather than the one it answers. Two people in this thread mean different things by Publishing an inconvenient result and are…
Why "add 2 mL" is not an instruction Replied, post #17 · Practice › Reconstitution · 13 Dec 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #66 · Compounds › Oral incretins · 26 Nov 2025 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
What a purity-only report leaves out Replied, post #96 · Sourcing › Independent verification · 21 Nov 2025 · 10 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #74 · Analytics › COA interpretation · 20 Nov 2025 · 3 likes Post #70 describes the usual case. This is about the unusual one. Residual solvent screening is not standard on these documents and its presence is a signal about the…
How to read a forest plot, properly, from scratch Replied, post #46 · Evidence › Trials · 26 Oct 2025 · 0 likes Post #45 answers the question as asked. The question underneath it is different. Risk of bias: structured appraisal of internal validity. Key things to assess:…
Reconciling a supplier certificate with an independent result Replied, post #14 · Sourcing › Vendor reports · 25 Oct 2025 · 4 likes The format we ask for is compound, lot, testing service, method as reported, result, and the certificate figure for the same lot. A report missing any of those goes to…
Documentation that appears only after payment Replied, post #53 · Sourcing › Red flags · 19 Oct 2025 · 0 likes Whatever the answer on documentation turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #21 · Documentation › Doc review · 14 Oct 2025 · 0 likes Worth separating two things that post #20 runs together. Check the arithmetic in every worked example by hand. A wrong worked example is worse than no example and…
History of disordered eating and why it changes the conversation Replied, post #14 · Clinical › Special populations · 23 Sep 2025 · 23 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short. On balance I…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #77 · Devices › Cold chain · 16 Sep 2025 · 8 likes Practical experience of Airline travel, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
MHRA statements, read directly Replied, post #2 · marked as the solution · Regional › UK & Ireland · 9 Sep 2025 · 12 likes Narrowing the opening post, because the general version has more than one answer. A note on how MHRA statements gets discussed rather than on MHRA statements itself:…
Follow-up: Why appetite effects are mostly central Replied, post #26 · Pharmacology › Receptor biology · 26 Aug 2025 · 5 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #48 · Practice › Side effects · 23 Aug 2025 · 0 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
Publishing an inconvenient result: a case study Replied, post #68 · Sourcing › Independent verification · 18 Aug 2025 · 30 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Hypertension improvement and when medication needs revisiting Replied, post #5 · Clinical › Comorbidities · 11 Aug 2025 · 16 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
A request that was declined, and the reasoning — a second dataset Replied, post #31 · Documentation › Wiki requests · 8 Aug 2025 · 27 likes Link the topics that prompted the request. The discussion is the evidence that the question recurs.
Enforcement priorities versus written rules — does this still hold? Replied, post #3 · Sourcing › Regulatory · 8 Aug 2025 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. Anything written here about regulatory status should be assumed stale after…
Are there stupid questions here? A staff answer, at length Replied, post #45 · Start Here › Welcome · 6 Aug 2025 · 33 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Travel coolers and how long they really hold Replied, post #28 · Devices › Cold chain · 2 Aug 2025 · 14 likes Thank you — that answers what I came here to find out.
A preprint whose numbers changed substantially at publication Replied, post #7 · Evidence › Preprints · 1 Aug 2025 · 20 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do.
Journal club: STEP 8 and the fairness of the comparator dose Replied, post #5 · Evidence › Journal club · 24 Jul 2025 · 1 like Second this, and I would have said it less carefully.
Immortal time bias in a claims-database study Replied, post #3 · Evidence › Study critique · 19 Jul 2025 · 5 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
A field-by-field walk through a certificate of analysis Replied, post #134 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes I have three months of notes on field-by-field walk through a certificate and the honest summary is that the trend is real and the week-to-week numbers are noise. I…
Journal club: STEP 3 and the intensive behavioural therapy floor — does this still hold? Started this topic · Evidence › Journal club · 17 Jul 2025 · 44 likes The question in the title: Journal club: STEP 3 and the intensive behavioural therapy floor — does this still hold? I will give what I have already checked below so…
Half-life, steady state, and accumulation worked through Replied, post #84 · Pharmacology › Pharmacokinetics · 8 Jun 2025 · 3 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #7 · Evidence › Trials · 31 May 2025 · 1 like Building on post #4 rather than restating it. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple…
Albumin binding and how it produces a long half-life Replied, post #39 · Pharmacology › Pharmacokinetics · 22 May 2025 · 0 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. Adding a source would…
Antibiotics and a course of something with delayed emptying Replied, post #46 · Practice › Interactions · 21 May 2025 · 3 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #72 · Sourcing › Independent verification · 10 May 2025 · 1 like Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Follow-up: What other technical communities get right that we do not Replied, post #81 · Lounge › Off topic · 28 Apr 2025 · 15 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
Scheduled maintenance and what will be unavailable Replied, post #82 · Meta › Announcements · 22 Mar 2025 · 14 likes That is the distinction I keep failing to hold on to. Written down now.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #28 · Compounds › Tirzepatide · 21 Mar 2025 · 31 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #7 · Evidence › Journal club · 22 Feb 2025 · 1 like Adding the measurement that post #4 says would settle it. SURMOUNT-OSA is a good example of a question where the honest answer is boring and the interesting answers are…
Protein density versus volume when you cannot eat much Replied, post #103 · Nutrition & Training › Protein & intake · 10 Feb 2025 · 0 likes Protein density versus volume would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Protein density versus volume when you cannot eat much Replied, post #8 · Nutrition & Training › Protein & intake · 23 Jan 2025 · 0 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
What we do not know about retatrutide, listed explicitly Replied, post #66 · Compounds › Retatrutide · 23 Jan 2025 · 16 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
Second pass at: Certificates issued by the seller versus by a laboratory Started this topic · Analytics › COA interpretation · 12 Jan 2025 · 8 likes Second pass at: Certificates issued by the seller versus by a laboratory — setting out what I have, and where I think it stops being reliable. Two reports on the same…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #121 · Compounds › Oral incretins · 28 Dec 2024 · 21 likes The arithmetic in post #120 is right; the assumption feeding it is the part to check. Trial adherence in an oral trial with strict administration requirements is…
What changed in 2026, by region Replied, post #6 · Access › International · 2 Dec 2024 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. Not a strong…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #15 · Practice › Reconstitution · 15 Nov 2024 · 5 likes Post #14 answers the question as asked. The question underneath it is different. A cake that takes a few minutes to dissolve is ordinary. A cake that will not dissolve…
Time to steady state after a dose increase Replied, post #98 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Adding the measurement that post #95 says would settle it. Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that…
Blind submission and why it changes minds Replied, post #51 · Sourcing › Independent verification · 2 Sep 2024 · 27 likes Where I would push back on the blind submission consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
High-resolution MS on aggregates and what it can see — one year on Replied, post #36 · Analytics › Mass spectrometry · 17 Aug 2024 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
The mass-error checker and its intended scope Replied, post #152 · Data & Tools › Calculators · 25 Jul 2024 · 1 like If you are new and reading this thread for the answer to mass-error checker: the answer is conditional, the conditions are in the third reply, and the rest of the…